  See all
 |
Articles: Pharmacology/Therapy |
Prior Articles
Neoadjuvant endocrine treatment in primary breast cancer – Review of literature
The Breast, 10/28/09
Adjuvant Chemotherapy in Localized Soft Tissue Sarcomas: Still Not Proven
The Oncologist, 10/28/09 Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era
The Oncologist, 10/28/09
Free full text
New Advances in the Second-Line Treatment of Small Cell Lung Cancer
The Oncologist, 10/28/09 Should Patients with High-Risk Soft Tissue Sarcoma Receive Adjuvant Chemotherapy
The Oncologist, 10/28/09 Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A
Journal of Thrombosis and Haemostasis, 10/28/09 Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report
Cancer Chemotherapy and Pharmacology, 10/28/09 Tamoxifen and arrhythmia
Medical Oncology, 10/28/09 Geldanamycin and its anti-cancer activities
Cancer Letters, 10/28/09 Thrombotic microangiopathy following docetaxel and trastuzumab chemotherapy: a case report
Medical Oncology, 10/28/09 Intracranial tumor lysis and cerebral edema after administration of intrathecal methotrexate: a case report and discussion
Medical Oncology, 10/28/09 Reirradiation for progressive brain metastases
Journal of Cancer Research and Therapeutics, 10/27/09 Cost of care of haemophilia with inhibitors
Haemophilia, 10/27/09 Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status
Journal of Neuro-Oncology, 10/27/09 Preliminary results of SIB-IMRT in head and neck cancers: Report from a regional cancer center in northern India
Journal of Cancer Research and Therapeutics, 10/27/09
Free full text
Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers
Journal of Cancer Research and Therapeutics, 10/27/09
Free full text
A phase II trial of capecitabine and docetaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with stage II/III breast cancer
Annals of Oncology, 10/26/09 Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase III study
The Lancet, 10/26/09 Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: CCTGcctg and SWOG study N0426
Journal of Clinical Oncology, 10/26/09 Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer
Cancer, 10/26/09
Exclusive Author Commentary
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
